April 27th, 2022
AcureX Therapeutics is awarded a new grant from The Michael J. Fox Foundation
to accelerate development of it's Parkinson's disease biomarker for drug development and clinical trials

October 12th, 2021
AcureX Therapeutics is awarded a SBIR grant from the National Institute on Aging, part of the National Institutes of Health 

October 1st, 2021
AcureX Therapeutics is featured by the Stanford SPARK Program

September 9th, 2021
AcureX Therapeutics' inventor/co-founder and AcureX scientist publish a ground-breaking discovery in Nature Metabolism, accompanied by an associated editorial

August 31st, 2021
AcureX Therapeutics receives grant funding from The Silverstein Foundation for Parkinson's with GBA